Latest Breaking News On - Femasys inc - Page 4 : comparemela.com

Femasys' FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF -February 28, 2024 at 09:02 am EST

Femasys readies for the commercial launch of FemaSeed® in the U.S. amidst the uncertainty following the Alabama Supreme Court Ruling on how to handle embryos used for in vitro fertilization .

Canada
Alabama
United-states
Femasy-fembloc
Femasy-femaseed
Chuck-padala
Kathy-lee-sepsick
Alabama-supreme-court
Nasdaq
Lifesci-advisors
Linkedin
Alabama-supreme-court-ruling

Femasys' FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF

Femasys' FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Alabama
United-states
Alabama-supreme-court-ruling
Femasys-inc

First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks - Aspira Womens Health (NASDAQ:AWH), Dare Bioscience (NASDAQ:DARE)

Jill Biden announces $100 million in federal funding for women's health research, addressing underfunding and lack of awareness. ARPA-H Sprint for Women's Health aims to promote innovative solutions.

Cambridge
Cambridgeshire
United-kingdom
Massachusetts
United-states
Washington
Joe-biden
Femaseed-intratubal
Jill-biden
Bioscience-inc
Hologic-inc
Human-services

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women

UC Davis Medical Center, a top regional and nationally ranked medical center, is the third academic center to participate in the FemBloc pivotal trial since enrollment began last quarter -UC Davis.

Sacramento
California
United-states
Nevada
Oregon
Canada
Femasy-fembloc
Femasy-femaseed
Kathy-lee-sepsick
Chuck-padala
Mitchell-creinin
Femasys-inc

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology

- University of Utah Hospital, Lori Gawron, M.D. of the Obstetrics and Gynecology Department, was an instrumental investigator in Femasys’ earlier FemBloc study - - FemBloc is being developed as a.

University-of-utah-hospital
Utah
United-states
Canada
University-of-utah
Chuck-padala
Femasy-fembloc
Kathy-lee-sepsick
Femasy-femaseed
Lori-gawron
Facebook
Nasdaq